December 2017 - FRMC

Volume
14
Issue 12
December 2017

FEATURES

Under changing leadership at the HHS, significant changes are likely to come for the ACA. | Read More
Citation:

By Jill Sederstrom

Anthem recently began rolling out a restrictive outpatient imaging policy, banning the services at hospitals when they are deemed clinically unnecessary. | Read More
Citation:

By Paul Nicolaus

Patients can sometimes be seen by out-of-network providers in in-network facilities, leaving them stuck with surprisingly high health bills. | Read More
Citation:
After a year of efforts to repeal the ACA, Obamacare still remains “the law of the land,” and the bill’s future remains unclear. | Read More
Citation:

DEPARTMENTS

By David Costill

Spotlight on the Oncology Pipeline, a session at AMCP Nexus 2017, highlighted three recent and upcoming cancer drug approvals. | Read More
Citation:
An investigation into 30-day Medicare spending among patients hospitalized with acute myocardial infarction (AMI) found that spending varies across hospitals | Read More
Citation:
Data from the COMPASS trial, presented at the AHA 2017 Scientific Sessions, found that a regimen of Xarelto (rivaroxaban; Janssen) with 100 mg of aspirin reduced hospitalization, and health services costs among patients with stable atherosclerotic vascular disease. | Read More
Citation:
Data presented at the AHA 2017 Scientific Sessions found that all-cause mortality among patients undergoing transcatheter aortic valve replacement (TAVR) was not significantly different compared with patients undergoing surgical aortic valve replacement (SAVR). | Read More
Citation: